Picture Berlin Partner Top News Amboss Secures EUR240m Funding 650x100px

Product › Details

clinical research

	Next higher product group	pharma services

Record changed: 2024-07-30

Picture Swiss Biotech Association Global Village 2025 SBD25 Basel 650x200px

More documents for clinical research

[1] Valneva S.E.. (4/9/25). "Press Release: Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2". Saint Herblain & Schlieren....
[2] CureVac N.V.. (4/7/25). "Press Release: CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer". Tübingen & Boston, MA....
[3] SmartDyeLivery GmbH. (4/2/25). "Press Release: SmartDyeLivery Starts First Clinical Study with Polymeric Nanocarriers". Jena, Erfurt & Berlin....
[4] Bayer AG. (3/26/25). "Press Release: Bayer and Puhe BioPharma Enter into Global License Agreement for Clinical Phase I PRMT5 inhibitor [Not intended for U.S. and UK Media]". Berlin & Beijing....
[5] Boehringer Ingelheim. (2/20/25). "Press Release: Boehringer Ingelheim and Partners Start Clinical Development of a First-in-Class, Inhaled Gene Therapy for People with Cystic Fibrosis". Ingelheim....
[6] Tubulis GmbH. (1/30/25). "Press Release: Tubulis Announces First Patient Dosed in Phase I/IIa Trial Evaluating ADC TUB-030 in Advanced Solid Tumors". Munich....
[7] Boehringer Ingelheim. (1/16/25). "Press Release: Boehringer Provides Update on Iclepertin Phase III Program in Schizophrenia". Ingelheim....
[8] CoreMedic GmbH. (1/10/25). "Press Release: CoreMedic Announces Partnership with InnoRa for Clinical Development of Transcatheter Mitral Valve Repair Device ChordArt". Basel & Philadelphia, PA....
[9] Eisbach Bio GmbH. (11/26/24). "Press Release: Eisbach Bio Secures CPRIT Grant to Advance Novel Cancer Therapeutic". Martinsried....
[10] TME Pharma N.V.. (10/31/24). "Press Release: TME Pharma Awarded €2.4 Million German Federal Grant to Support NOX-A12 Phase 2 Trial in Brain Cancer". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)